VVARDIS Unveils Drill-Free Cavity Treatment at Healthcare Conference

Swiss healthcare company vVARDIS, led by founders Drs. Haley and Goly Abivardi, presented their drill-free cavity treatment, Curodont™, at the 2026 J.P. Morgan Healthcare Conference in San Francisco. This event highlighted their innovative approach in oral healthcare, emphasizing their non-invasive solution for early-stage cavities. Curodont™, since its U.S. launch two years prior, has treated over 2 million teeth, underscoring its rapid market acceptance and growth.

At the conference, vVARDIS also introduced a public health campaign, “Save Teeth Save Lives,” aiming to increase awareness about cavity prevention. The campaign stresses the interconnectedness of oral and overall health, advocating for early intervention. This initiative targets the widespread occurrence of cavities, the most common chronic disease globally, aiming to change dental care approaches.

With backing from investors like OrbiMed and partnerships with companies such as Henry Schein, vVARDIS has expanded its reach significantly in North America. Their focus remains on transforming oral care with a product that is already being adopted across 12% of U.S. dental offices.